Zymeworks (ZYME): Evaluating Valuation After New Oncology Leadership and Renewed Pipeline Momentum

Zymeworks (ZYME) made headlines with the appointment of Adam Schayowitz, Ph.D., MBA, as Acting Chief Development Officer. Dr. Schayowitz’s arrival adds oncology expertise and could provide new ...